mbiomics vs Slate Medicines
mbiomics vs Slate Medicines, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: mbiomics is on 48/100 and Slate Medicines on 41/100.
Where each one leads
mbiomics
- our overall score: 48/100 against 41/100
Slate Medicines
- agent readiness: 51/100 against 42/100
- domain rating: 14/100 against 9/100
- funding raised: $130M against $12.0M
At a glance
| Measure | mbiomics | Slate Medicines |
|---|---|---|
| What it is | Advancing scalable microbiome-based therapeutics for severe and chronic diseases. | Advancing anti-PACAP therapies for the prevention of migraine and other headache disorders. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Artificial Intelligence | Biotechnology, Pharmaceuticals, Therapeutics, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2024 |
| Headquarters | Munich, Germany | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | mbiomics | Slate Medicines |
|---|---|---|
| Total funding | $12.0M | $130M |
| Latest round | Series A | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | mbiomics | Slate Medicines |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 41/100 |
| Traction | 35/100 | 40/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 2/100 | 14/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (51/100) |
| Domain ratingLink authority, 0-100 | 9/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | mbiomics | Slate Medicines |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Framer | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
mbiomics vs Slate Medicines: common questions
Which is better, mbiomics or Slate Medicines?
On our 0-100 score mbiomics rates higher (48/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do mbiomics and Slate Medicines compare on the numbers?
mbiomics leads on our overall score (48/100 against 41/100). Slate Medicines leads on agent readiness (51/100 against 42/100), domain rating (14/100 against 9/100), funding raised ($130M against $12.0M).
Read the full mbiomics review and pricing or the Slate Medicines review and pricing. You can also browse other mbiomics alternatives we track.